Patents by Inventor Atle Noralf LARSEN
Atle Noralf LARSEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230332118Abstract: The present invention relates to enzymes having DNA polymerase and 3?-5? exonuclease activities. In particular, the present invention relates to a heat labile enzyme possessing a DNA polymerase II activity and a 3?-5? exonuclease activity of marine origin. Furthermore, the present invention relates to a DNA polymerase primarily exerting a 3?-5? activity, i.e. where the polymerase activity is absent. The present invention furthermore relates to the use of the exonuclease activity to degrade the 3?-5? strand of double stranded DNA to perform single stranded overhang, e.g. in recombinant cloning processes, or in processes for removal of contaminating nucleic acid molecules.Type: ApplicationFiled: October 1, 2020Publication date: October 19, 2023Inventors: Atle Noralf Larsen, Yvonne Piotrowski
-
Publication number: 20230220435Abstract: The present invention relates to recombinant DNA technology, in particular to methods for assembling two or more double stranded (ds) nucleic acid molecules with overlapping terminal sequences. In particular, the present invention relates to the use of a thermolabile DNA polymerase II derived 3?-5? exonuclease isolated from Moritella viscoa and a thermolabile DNA polymerase I of marine origin in multi DNA assembly processes.Type: ApplicationFiled: October 1, 2020Publication date: July 13, 2023Inventors: Yvonne Piotrowski, Atle Noralf Larsen
-
Publication number: 20230220449Abstract: The present invention relates to DNA polymerases. In particular, the present invention relates to heat labile DNA polymerases of marine origin, having high polymerase activity, strand displacement activity and 3-5? exonuclease activity. Furthermore, the present invention provides heat labile DNA polymerases substantially without strand-displacement activity.Type: ApplicationFiled: October 1, 2020Publication date: July 13, 2023Inventors: Atle Noralf Larsen, Yvonne Piotrowski
-
Publication number: 20230034466Abstract: The present invention provides a DNA polymerase including the sequence of SEQ ID NO. 1 or a sequence which is at least 70% identical thereto, but wherein the aspartic acid residue at position 18 of SEQ ID NO. 1, or the equivalent aspartic acid residue in other sequences, has been replaced by a non-negatively charged amino acid residue. It further provides DNA polymerases comprising the amino acid sequences of SEQ ID NO. 2, 11 and 12 and variants thereof. The present invention also provides nucleic acids encoding the DNA polymerases, a method of producing said DNA polymerases, and compositions, expression vectors and host cells or viruses comprising said DNA polymerases. The present invention also provides uses of said DNA polymerases in nucleotide polymerisation, amplification, and sequencing reactions.Type: ApplicationFiled: June 10, 2022Publication date: February 2, 2023Inventors: Atle Noralf LARSEN, Yvonne PIOTROWSKI
-
Patent number: 11390857Abstract: The present invention provides a DNA polymerase including the sequence of SEQ ID NO. 1 or a sequence which is at least 70% identical thereto, but wherein the aspartic acid residue at position 18 of SEQ ID NO. 1, or the equivalent aspartic acid residue in other sequences, has been replaced by a non-negatively charged amino acid residue. It further provides DNA polymerases comprising the amino acid sequences of SEQ ID NO. 2, 11 and 12 and variants thereof. The present invention also provides nucleic acids encoding the DNA polymerases, a method of producing said DNA polymerases, and compositions, expression vectors and host cells or viruses comprising said DNA polymerases. The present invention also provides uses of said DNA polymerases in nucleotide polymerisation, amplification and sequencing reactions.Type: GrantFiled: December 17, 2018Date of Patent: July 19, 2022Assignee: UNIVERSITETET I TROMSØ—NORGES ARTISKE UNIVERSITETInventors: Atle Noralf Larsen, Yvonne Piotrowski
-
Publication number: 20200332352Abstract: The invention provides an exonuclease or an enzymatically active fragment thereof, said exonuclease having the amino acid sequence of SEQ ID NO:1 or an amino acid sequence which is at least about 50% identical thereto, wherein said exonuclease or enzymatically active fragment thereof (i) is substantially irreversibly inactivated by heating at a temperature of about 55° C. for 10 minutes in a buffer consisting of 10 mM Tris-HCl, pH 8.5 at 25° C., 50 mM KCl and 5 mM MgCl2; (ii) is substantially specific for single stranded DNA; and (iii) has a 3?-5? exonuclease activity. The invention further provides a method of removing single stranded DNA from a sample, a method of nucleic acid amplification, a method of reverse transcription and a method of nucleic acid sequence analysis in which the exonuclease or enzymatically active fragment thereof is used.Type: ApplicationFiled: August 13, 2019Publication date: October 22, 2020Applicants: ArcticZymes AS, Universitetet I Tromsø - Norges Arktiske UniversitetInventors: Terese SOLSTAD, Elisabeth Lill ANDREASSEN, Marit Sjo LORENTZEN, Olav LANES, Morten ELDE, Atle Noralf LARSEN, Yvonne PIOTROWSKI, Nils Peder WILLASSEN
-
Publication number: 20200325459Abstract: The present invention provides a DNA polymerase including the sequence of SEQ ID NO. 1 or a sequence which is at least 70% identical thereto, but wherein the aspartic acid residue at position 18 of SEQ ID NO. 1, or the equivalent aspartic acid residue in other sequences, has been replaced by a non-negatively charged amino acid residue. It further provides DNA polymerases comprising the amino acid sequences of SEQ ID NO. 2, 11 and 12 and variants thereof. The present invention also provides nucleic acids encoding the DNA polymerases, a method of producing said DNA polymerases, and compositions, expression vectors and host cells or viruses comprising said DNA polymerases. The present invention also provides uses of said DNA polymerases in nucleotide polymerisation, amplification and sequencing reactions.Type: ApplicationFiled: December 17, 2018Publication date: October 15, 2020Inventors: Atle Noralf LARSEN, Yvonne PIOTROWSKI
-
Patent number: 10787653Abstract: The present invention relates to DNA polymerases. In particular, the present invention relates to DNA polymerases based on a DNA polymerase from a Psychrobacillus sp. The present invention provides an isolated DNA polymerase or an enzymatically active fragment thereof, said DNA polymerase comprising the amino acid sequence of SEQ ID NO:1 or comprising an amino acid sequence which is at least 70% identical to SEQ ID NO:1. The invention also provides nucleic acid molecules comprising a nucleotide sequence that encodes the DNA polymerase. The invention also provides a method of nucleotide polymerisation and a method of amplifying a nucleic acid in which the DNA polymerase or an enzymatically active fragment thereof is used.Type: GrantFiled: March 22, 2017Date of Patent: September 29, 2020Assignee: UNIVERSITETET I TROMSØ—NORGES ARKTISKE UNIVERSITETInventors: Atle Noralf Larsen, Yvonne Piotrowski, Netsanet Gizaw Assefa, Olav Lanes
-
Patent number: 10787702Abstract: The invention provides an exonuclease or an enzymatically active fragment thereof, said exonuclease having the amino acid sequence of SEQ ID NO:1 or an amino acid sequence which is at least about 50% identical thereto, wherein said exonuclease or enzymatically active fragment thereof (i) is substantially irreversibly inactivated by heating at a temperature of about 55° C. for 10 minutes in a buffer consisting of 10 mM Tris-HCl, pH 8.5 at 25° C., 50 mM KCl and 5 mM MgCl2; (ii) is substantially specific for single stranded DNA; and (iii) has a 3?-5? exonuclease activity. The invention further provides a method of removing single stranded DNA from a sample, a method of nucleic acid amplification, a method of reverse transcription and a method of nucleic acid sequence analysis in which the exonuclease or enzymatically active fragment thereof is used.Type: GrantFiled: August 13, 2019Date of Patent: September 29, 2020Assignees: ARCTICZYMES AS, UNIVERSITETET I TROMSø—NORGES ARKTISKE UNIVERSITETInventors: Terese Solstad, Elisabeth Lill Andreassen, Marit Sjo Lorentzen, Olav Lanes, Morten Elde, Atle Noralf Larsen, Yvonne Piotrowski, Nils Peder Willassen
-
Publication number: 20200071753Abstract: The invention provides an exonuclease or an enzymatically active fragment thereof, said exonuclease having the amino acid sequence of SEQ ID NO:1 or an amino acid sequence which is at least about 50% identical thereto, wherein said exonuclease or enzymatically active fragment thereof (i) is substantially irreversibly inactivated by heating at a temperature of about 55° C. for 10 minutes in a buffer consisting of 10 mM Tris-HCl, pH 8.5 at 25° C., 50 mM KCl and 5 mM MgCl2; (ii) is substantially specific for single stranded DNA; and (iii) has a 3?-5? exonuclease activity. The invention further provides a method of removing single stranded DNA from a sample, a method of nucleic acid amplification, a method of reverse transcription and a method of nucleic acid sequence analysis in which the exonuclease or enzymatically active fragment thereof is used.Type: ApplicationFiled: August 13, 2019Publication date: March 5, 2020Applicants: ArcticZymes AS, Universitetet I Tromsø - Norges Arktiske UniversitetInventors: Terese SOLSTAD, Elisabeth Lill ANDREASSEN, Marit Sjo LORENTZEN, Olav LANES, Morten ELDE, Atle Noralf LARSEN, Yvonne PIOTROWSKI, Nils Peder WILLASSEN
-
Patent number: 10415082Abstract: The invention provides an exonuclease or an enzymatically active fragment thereof, said exonuclease having the amino acid sequence of SEQ ID NO:1 or an amino acid sequence which is at least about 50% identical thereto, wherein said exonuclease or enzymatically active fragment thereof (i) is substantially irreversibly inactivated by heating at a temperature of about 55° C. for 10 minutes in a buffer consisting of 10 mM Tris-HCl, pH 8.5 at 25° C., 50 mM KCl and 5 mM MgCl2; (ii) is substantially specific for single stranded DNA; and (iii) has a 3?-5? exonuclease activity. The invention further provides a method of removing single stranded DNA from a sample, a method of nucleic acid amplification, a method of reverse transcription and a method of nucleic acid sequence analysis in which the exonuclease or enzymatically active fragment thereof is used.Type: GrantFiled: August 28, 2018Date of Patent: September 17, 2019Assignees: ARCTICZYMES AS, UNIVERSITETET I TROMSø—NORGES ARKTISKE UNIVERSITETInventors: Terese Solstad, Elisabeth Lill Andreassen, Marit Sjo Lorentzen, Olav Lanes, Morten Elde, Atle Noralf Larsen, Yvonne Piotrowski, Nils Peder Willassen
-
Publication number: 20190106686Abstract: The present invention relates to DNA polymerases. In particular, the present invention relates to DNA polymerases based on a DNA polymerase from a Psychrobacillus sp. The present invention provides an isolated DNA polymerase or an enzymatically active fragment thereof, said DNA polymerase comprising the amino acid sequence of SEQ ID NO:1 or comprising an amino acid sequence which is at least 70% identical to SEQ ID NO:1. The invention also provides nucleic acid molecules comprising a nucleotide sequence that encodes the DNA polymerase. The invention also provides a method of nucleotide polymerisation and a method of amplifying a nucleic acid in which the DNA polymerase or an enzymatically active fragment thereof is used.Type: ApplicationFiled: March 22, 2017Publication date: April 11, 2019Applicant: Universitetet I Tromsø - Norges Arktiske UniversitetInventors: Atle Noralf LARSEN, Yvonne PIOTROWSKI, Netsanet Gizaw ASSEFA, Olav LANES
-
Publication number: 20180363042Abstract: The invention provides an exonuclease or an enzymatically active fragment thereof, said exonuclease having the amino acid sequence of SEQ ID NO:1 or an amino acid sequence which is at least about 50% identical thereto, wherein said exonuclease or enzymatically active fragment thereof (i) is substantially irreversibly inactivated by heating at a temperature of about 55° C. for 10 minutes in a buffer consisting of 10 mM Tris-HCl, pH 8.5 at 25° C., 50 mM KCl and 5 mM MgCl2; (ii) is substantially specific for single stranded DNA; and (iii) has a 3?-5? exonuclease activity. The invention further provides a method of removing single stranded DNA from a sample, a method of nucleic acid amplification, a method of reverse transcription and a method of nucleic acid sequence analysis in which the exonuclease or enzymatically active fragment thereof is used.Type: ApplicationFiled: August 28, 2018Publication date: December 20, 2018Applicants: ArcticZymes AS, Universitetet I Tromsø - Norges Arktiske UniversitetInventors: Terese Solstad, Elisabeth Lill Andreassen, Marit Sjo Lorentzen, Olav Lanes, Morten Elde, Atle Noralf Larsen, Yvonne Piotrowski, Nils Peder Willassen
-
Patent number: 10087483Abstract: The invention provides an exonuclease or an enzymatically active fragment thereof, said exonuclease having the amino acid sequence of SEQ ID No. 1 or an amino acid sequence which is at least about 50% identical thereto, wherein said exonuclease or enzymatically active fragment thereof (i) is substantially irreversibly inactivated by heating at a temperature of about 55° C. for 10 minutes in a buffer consisting of 10 mM Tris-HCI, pH 8.5 at 25° C., 50 mM KCI and 5 mM MgCI2; (ii) is substantially specific for single stranded DNA; and (iii) has a 3?-5? exonuclease activity. The invention further provides a method of removing single stranded DNA from a sample, a method of nucleic acid amplification, a method of reverse transcription and a method of nucleic acid sequence analysis in which the exonuclease or enzymatically active fragment thereof is used.Type: GrantFiled: August 19, 2015Date of Patent: October 2, 2018Assignees: ARCTICZYMES AS, UNIVERSITETET I TROMSØ—NORGES ARKTISKE UNIVERSITETInventors: Terese Solstad, Elisabeth Lill Andreassen, Marit Sjo Lorentzen, Olav Lanes, Morten Elde, Atle Noralf Larsen, Yvonne Piotrowski, Nils Peder Willassen
-
Publication number: 20170233800Abstract: The invention provides an exonuclease or an enzymatically active fragment thereof, said exonuclease having the amino acid sequence of SEQ ID No. 1 or an amino acid sequence which is at least about 50% identical thereto, wherein said exonuclease or enzymatically active fragment thereof (i) is substantially irreversibly inactivated by heating at a temperature of about 55° C. for 10 minutes in a buffer consisting of 10 mM Tris-HCl, pH 8.5 at 25° C., 50 mM KCl and 5 mM MgCl2; (ii) is substantially specific for single stranded DNA; and (iii) has a 3?-5? exonuclease activity. The invention further provides a method of removing single stranded DNA from a sample, a method of nucleic acid amplification, a method of reverse transcription and a method of nucleic acid sequence analysis in which the exonuclease or enzymatically active fragment thereof is used.Type: ApplicationFiled: August 19, 2015Publication date: August 17, 2017Applicants: ArcticZymes AS, Universitetet I Tromsø - Norges Arktiske UniversitetInventors: Terese SOLSTAD, Elisabeth Lill ANDREASSEN, Marit Sjo LORENTZEN, Olav LANES, Morten ELDE, Atle Noralf LARSEN, Yvonne PIOTROWSKI, Nils Peder WILLASSEN